卖什么
动物医疗初创公司
商业模式拆解
买家：谁掌握预算？
未核实Veterinary clinics and owners; likely pharma/animal-health licensing partners.
触发点：什么让他们现在购买？
FIP is often fatal within weeks, no effective vaccine exists and unapproved treatments cost tens of thousands of dollars.
工作流：什么输入变成什么输出？
Integrated prevention plus testing approach; lead FECV control drug OU-500 identified from Oita University compound library and screened at Kitasato University.
经济账：省了什么，怎么收费？
未核实Pre-revenue drug development; commercialisation via approved product or partnership (not stated).
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-02-12 | 种子轮 | — | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.